Alx Oncology Holdings (ALXO) Other financing activities (2021 - 2026)

Alx Oncology Holdings (ALXO) posted Other financing activities of $3000.0 for Q1 2026, down 86.96% sequentially from $23000.0 in Q4 2025.

Alx Oncology Holdings (ALXO) Other financing activities (2021 - 2026) Analysis & Trends

Alx Oncology Holdings has reported Other financing activities for 6 years, with the latest figure at $3000.0 in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12000.0 (changed N/A YoY) and the FY2025 annual result came in at $24000.0, down 98.53% from the prior year.
Other financing activities eased to $3000.0 in Q1 2026 per ALXO's latest filing, from $23000.0 in the prior quarter.
Over five years, Other financing activities peaked at $1.3 million in Q3 2024 and troughed at -$38000.0 in Q3 2022.
A 5-year average of $194272.7 and a median of $69000.0 in 2024 frame the typical range for Other financing activities.
The sharpest annual moves came in 2022 and 2023: Other financing activities slumped 107.0% in 2022, then soared 361.76% in 2023.
Over 5 years, Other financing activities stood at $34000.0 in 2022, then jumped by 361.76% to $157000.0 in 2023, then jumped by 744.59% to $1.3 million in 2024, then slumped by 98.27% to $23000.0 in 2025, then tumbled by 86.96% to $3000.0 in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $3000.0, $23000.0, and -$14000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Alx Oncology Holdings	270.90 Mn	270.90 Mn	-

Download Data